The European Bioinformatics Institute: empowering cooperation in response to a global health crisis.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
08 01 2021
Historique:
accepted: 22 10 2020
revised: 20 10 2020
received: 24 09 2020
pubmed: 28 11 2020
medline: 26 1 2021
entrez: 27 11 2020
Statut: ppublish

Résumé

The European Bioinformatics Institute (EMBL-EBI; https://www.ebi.ac.uk/) provides freely available data and bioinformatics services to the scientific community, alongside its research activity and training provision. The 2020 COVID-19 pandemic has brought to the forefront a need for the scientific community to work even more cooperatively to effectively tackle a global health crisis. EMBL-EBI has been able to build on its position to contribute to the fight against COVID-19 in a number of ways. Firstly, EMBL-EBI has used its infrastructure, expertise and network of international collaborations to help build the European COVID-19 Data Platform (https://www.covid19dataportal.org/), which brings together COVID-19 biomolecular data and connects it to researchers, clinicians and public health professionals. By September 2020, the COVID-19 Data Platform has integrated in excess of 170 000 COVID-19 biomolecular data and literature records, collected through a number of EMBL-EBI resources. Secondly, EMBL-EBI has strived to continue its support of the life science communities through the crisis, with updated Training provision and improved service provision throughout its resources. The COVID-19 pandemic has highlighted the importance of EMBL-EBI's core principles, including international cooperation, resource sharing and central data brokering, and has further empowered scientific cooperation.

Identifiants

pubmed: 33245775
pii: 6007661
doi: 10.1093/nar/gkaa1077
pmc: PMC7778996
doi:

Substances chimiques

Viral Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

D29-D37

Subventions

Organisme : NHGRI NIH HHS
ID : U41 HG007823
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Eur J Hum Genet. 2020 Jun;28(6):719-723
pubmed: 32415272
Nucleic Acids Res. 2020 Jan 8;48(D1):D344-D353
pubmed: 31584092
Nucleic Acids Res. 2018 Mar 16;46(5):2699
pubmed: 29425356
Nucleic Acids Res. 2021 Jan 8;49(D1):D192-D200
pubmed: 33211869
Nucleic Acids Res. 2019 Jan 8;47(D1):D550-D558
pubmed: 30357405
Nucleic Acids Res. 2021 Jan 8;49(D1):D412-D419
pubmed: 33125078
Nucleic Acids Res. 2021 Jan 8;49(D1):D1507-D1514
pubmed: 33180112
Nucleic Acids Res. 2020 Jan 8;48(D1):D1145-D1152
pubmed: 31686107
Nucleic Acids Res. 2020 Jan 8;48(D1):D440-D444
pubmed: 31691833
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D452-5
pubmed: 14681455
Nucleic Acids Res. 2021 Jan 8;49(D1):D344-D354
pubmed: 33156333
Nucleic Acids Res. 2020 Jan 8;48(D1):D70-D76
pubmed: 31722421
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Cell. 2020 Aug 6;182(3):685-712.e19
pubmed: 32645325
Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503
pubmed: 31691815
Nucleic Acids Res. 2019 Jan 8;47(D1):D1056-D1065
pubmed: 30462303
Nucleic Acids Res. 2019 Jan 8;47(D1):D930-D940
pubmed: 30398643
Nucleic Acids Res. 2021 Jan 8;49(D1):D212-D220
pubmed: 33106848
Nucleic Acids Res. 2016 Jan 4;44(D1):D385-95
pubmed: 26476444
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Nat Genet. 2015 Jul;47(7):692-5
pubmed: 26111507
J Proteome Res. 2020 Oct 2;19(10):3906-3909
pubmed: 32786688
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Database (Oxford). 2019 Jan 1;2019:
pubmed: 31868882
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
Nature. 2020 Jul;583(7816):469-472
pubmed: 32408336
PLoS Genet. 2016 Jan 21;12(1):e1005772
pubmed: 26796797
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Bioinformatics. 2020 Apr 15;36(8):2636-2642
pubmed: 31950984

Auteurs

Gaia Cantelli (G)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.

Guy Cochrane (G)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.

Cath Brooksbank (C)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.

Ellen McDonagh (E)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.
Open Targets, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.

Paul Flicek (P)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.

Johanna McEntyre (J)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.

Ewan Birney (E)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.

Rolf Apweiler (R)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH